Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its decision to spin out its own candidate into a separate company. In September, Tiziana ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Some patients are suboptimal responders to anti-VEGF ...
Vaccine immunotherapy targeting interleukin 6 (IL-6) has shown promising results in the treatment of inflammatory osteoarthritis of the knee, according to a phase 1 double-blind controlled study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results